CSJA:FRA
CSL ADR
€30.60
arrow_upward
+1.32%(+0.40) 1D
Nob 4, 10:00:00 PM GMT+1 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa CSJA...
Buksan
€29.00
Mataas
€30.60
Mababa
€29.00
Mkt. cap
96.67B
Avg. na dami
10.00
Dami
0.00
Mataas nang 52-wk
€43.40
Mababa nang 52-wk
€12.70
Bilang ng mga empleyado
29K
Buksan
€29.00
Mataas
€30.60
Mababa
€29.00
Mkt. cap
96.67B
Avg. na dami
10.00
Dami
0.00
Mataas nang 52-wk
€43.40
Mababa nang 52-wk
€12.70
Bilang ng mga empleyado
29K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
The Motley Fool Australia
·
40 minuto ang nakalipas
CSL shares push past $200: Is $250 next?
Investing.com South Africa
·
10 oras ang nakalipas
Haemonetics earnings set to reveal CSL Plasma deal impact By Investing.com
Kalkine
·
15 oras ang nakalipas
ASX Share Prices: CSL (ASX:CSL) Names New CEO as FY27 Recovery Plan Takes Shape
Kalkine
·
1 araw ang nakalipas
CSL Limited (ASX:CSL): What FY26 Earnings Reveal About Its Biopharmaceutical Operations
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
Tungkol sa CSL ADR
CEOPaul McKenzie
Mga Empleyado29K
Itinatag1916
HeadquartersMelbourne, Victoria, Australia
Sektor-
Industry-
Websitecsl.com